Growth Metrics

Eton Pharmaceuticals (ETON) Cash from Financing Activities (2019 - 2025)

Eton Pharmaceuticals' Cash from Financing Activities history spans 7 years, with the latest figure at $421000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 98.75% to $421000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $815000.0, a 97.5% decrease, with the full-year FY2025 number at $815000.0, down 97.5% from a year prior.
  • Cash from Financing Activities hit $421000.0 in Q4 2025 for Eton Pharmaceuticals, up from $394000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for ETON hit a ceiling of $33.6 million in Q4 2024 and a floor of -$385000.0 in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $1.8 million across 5 years, with a median of -$7000.0 in 2022.
  • Biggest five-year swings in Cash from Financing Activities: crashed 1154.29% in 2023 and later soared 11519.05% in 2024.
  • Tracing ETON's Cash from Financing Activities over 5 years: stood at $68000.0 in 2021, then skyrocketed by 45.59% to $99000.0 in 2022, then tumbled by 396.97% to -$294000.0 in 2023, then soared by 11519.05% to $33.6 million in 2024, then tumbled by 98.75% to $421000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for ETON at $421000.0 in Q4 2025, $394000.0 in Q1 2025, and $33.6 million in Q4 2024.